Endoscopic surveillance of Lynch syndrome at a highly specialized center in Sweden: An observational study of interval colorectal cancer and individual risk factors

被引:4
作者
Jamizadeh, Nigin [1 ]
Bernstedt, Sophie Walton [1 ,2 ,3 ]
Haxhijaj, Adrianna [1 ]
Andreasson, Anna [1 ]
Bjork, Jan [2 ,4 ]
Forsberg, Anna [5 ]
Backman, Ann-Sofie [1 ,6 ]
机构
[1] Karolinska Inst, Dept Med Huddinge, Unit Gastroenterol, Stockholm, Sweden
[2] Karolinska Univ Hosp, Div Gastroenterol, Med Unit Gastroenterol Dermatovenereol & Rheumatol, Stockholm, Sweden
[3] Karolinska Univ Hosp, Div Upper Gastrointestinal Dis, Stockholm, Sweden
[4] Karolinska Univ Hosp, Hereditary Canc Unit, Theme Canc, Stockholm, Sweden
[5] Karolinska Inst, Dept Med Solna, Div Clin Epidemiol, Stockholm, Sweden
[6] Ersta Hosp, Dept Med, Div Gastroenterol, Stockholm, Sweden
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
Lynch syndrome (LS); colorectal cancer; interval cancer; surveillance; colonoscopy; ASPIRIN; PREVENTION; PHENOTYPE; ADENOMAS; FAMILIES; REGISTRY; PMS2;
D O I
10.3389/fonc.2023.1127707
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IntroductionLynch syndrome (LS) is the most common hereditary cause of colorectal cancer (CRC). In order to detect CRCs amongst LS patients, regular colonoscopies are recommended. However, an international agreement on an optimal surveillance interval has not yet been reached. In addition, few studies have investigated factors that could potentially increase the CRC risk amongst LS patients. AimsThe primary aim was to describe the frequency of CRCs detected during endoscopic surveillance and to estimate the interval from a clean colonoscopy to CRC detection amongst LS patients. The secondary aim was to investigate individual risk factors, including sex, LS genotype, smoking, aspirin use and body mass index (BMI), on CRC risk amongst patients that develop CRC before and during surveillance. Material and methodsClinical data and colonoscopy findings from 366 LS patients' 1437 surveillance colonoscopies were collected from medical records and patient protocols. Logistic regression and Fisher's exact test were used to investigate associations between individual risk factors and CRC development. Mann-Whitney U test was used to compare the distribution of TNM stages of CRC detected before surveillance and after index. ResultsCRC was detected in 80 patients before surveillance and in 28 patients during surveillance (10 at index and 18 after index). During the surveillance programme, CRC was detected within 24 months in 65% of the patients, and after 24 months within 35% of the patients. CRC was more common amongst men, previous and current smokers, and the odds of developing CRC also increased with an increasing BMI. CRCs were more often detected amongst MLH1 and MSH2 carriers during surveillance, compared to the other genotypes. ConclusionsWe found that 35% of the CRC cases detected during surveillance were found after 24 months. MLH1 and MSH2 carriers were at higher risk of developing CRC during surveillance. Additionally, men, current or previous smokers, and patients with a higher BMI were at higher risk of developing CRC. Currently, LS patients are recommended a "one-size-fits-all" surveillance program. The results support the development of a risk-score whereby individual risk factors should be taken into consideration when deciding on an optimal surveillance interval.
引用
收藏
页数:9
相关论文
共 28 条
  • [11] ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (Lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis)
    Hegde, Madhuri
    Ferber, Mathew
    Mao, Rong
    Samowitz, Wade
    Ganguly, Arupa
    [J]. GENETICS IN MEDICINE, 2014, 16 (01) : 101 - 116
  • [12] Meta-analyses of colorectal cancer risk factors
    Johnson, Constance M.
    Wei, Caimiao
    Ensor, Joe E.
    Smolenski, Derek J.
    Amos, Christopher I.
    Levin, Bernard
    Berry, Donald A.
    [J]. CANCER CAUSES & CONTROL, 2013, 24 (06) : 1207 - 1222
  • [13] Associations Between Mutations in MSH6 and PMS2 and Risk of Surveillance-detected Colorectal Cancer
    Lamba, Mehul
    Wakeman, Chris
    Ebel, Rosy
    Hamilton, Sarah
    Frampton, Chris
    Kiesanowski, Maxene
    Griffiths, Ben
    Keating, John
    Parry, Susan
    Chalmers-Watson, Teresa
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (12) : 2768 - 2774
  • [14] Incident colorectal cancer in Lynch syndrome is usually not preceded by compromised quality of colonoscopy
    Lappalainen, Jutta
    Holmstrom, Darja
    Lepistoe, Anna
    Saarnio, Juha
    Mecklin, Jukka-Pekka
    Seppala, Toni
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (12) : 1473 - 1480
  • [15] The IARC Perspective on Colorectal Cancer Screening
    Lauby-Secretan, Beatrice
    Vilahur, Nadia
    Bianchini, Franca
    Guha, Neela
    Straif, Kurt
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (18) : 1734 - 1740
  • [16] A Meta-Analysis of Obesity and Risk of Colorectal Cancer in Patients with Lynch Syndrome: The Impact of Sex and Genetics
    Lazzeroni, Matteo
    Bellerba, Federica
    Calvello, Mariarosaria
    Macrae, Finlay
    Win, Aung Ko
    Jenkins, Mark
    Serrano, Davide
    Marabelli, Monica
    Cagnacci, Sara
    Tolva, Gianluca
    Macis, Debora
    Raimondi, Sara
    Mazzarella, Luca
    Chiocca, Susanna
    Caini, Saverio
    Bertario, Lucio
    Bonanni, Bernardo
    Gandini, Sara
    [J]. NUTRIENTS, 2021, 13 (05)
  • [17] Risk Factors for the Diagnosis of Colorectal Cancer
    Lewandowska, Anna
    Rudzki, Grzegorz
    Lewandowski, Tomasz
    Stryjkowska-Gora, Aleksandra
    Rudzki, Slawomir
    [J]. CANCER CONTROL, 2022, 29
  • [18] Aspirin and folic acid for the prevention of recurrent colorectal adenomas
    Logan, Richard F. A.
    Grainge, Matfhew J.
    Shepherd, Vic C.
    Armitage, Nicholas C.
    Muir, Kenneth R.
    [J]. GASTROENTEROLOGY, 2008, 134 (01) : 29 - 38
  • [19] Smoking and Colorectal Cancer in Lynch Syndrome: Results from the Colon Cancer Family Registry and The University of Texas MD Anderson Cancer Center
    Pande, Mala
    Lynch, Patrick M.
    Hopper, John L.
    Jenkins, Mark A.
    Gallinger, Steve
    Haile, Robert W.
    LeMarchand, Loic
    Lindor, Noralane M.
    Campbell, Peter T.
    Newcomb, Polly A.
    Potter, John D.
    Baron, John A.
    Frazier, Marsha L.
    Amos, Christopher I.
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (04) : 1331 - 1339
  • [20] A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer
    Sandler, RS
    Halabi, S
    Baron, JA
    Budinger, S
    Paskett, E
    Keresztes, R
    Petrelli, N
    Pipas, JM
    Karp, DD
    Loprinzi, CL
    Steinbach, G
    Schilsky, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (10) : 883 - 890